Swedish startup Ironic Biotech raises €1M to help 2 billion people suffering from iron deficiency and anemia

Up to 25% of the world’s population, mostly women, suffer from different levels of iron deficiency or anemia. Ironic Biotech’s proprietary heme iron ingredient brings a scalable solution to the widely unaddressed problem, as the current solutions are highly inaccessible due to their price or harmful side effects.

LUND, Sweden (April 4th, 2024) Swedish biotech startup Ironic Biotech has successfully closed a pre-seed funding round of €1M, led by Nordic Foodtech VC. Ironic Biotech has discovered a new generation of plant-derived proteins that contain iron, which are highly bioavailable with no side effects. The proteins are produced through precision fermentation and may be used as ingredients in food or food supplements. The funding will be used for further R&D work, expanding the company’s patent portfolio, and optimizing the production process. The team is now looking for partners in the food and food supplement industry to work with.

Up to 25% of the world’s population suffers from iron deficiency. Lack of iron leads to severe exhaustion, fatigue, heart palpitations, learning disabilities, and anemia – symptoms that can be related to a mix of diseases or life situations, causing iron deficiency and anemia to go widely undetected, underdiagnosed, or completely ignored.

“We want to help 2 billion people to prevent and recover from iron deficiency and anemia. The lack of iron is partly responsible for the performance gap between males and females, as women naturally lose iron regularly. The situation is widely unaddressed – a sad story that applies to many female health issues, iron deficiency not being an exception,” says Dr. Nélida Leiva Eriksson, CEO and founder of Ironic Biotech. “I know what lack of iron can do to a person, as I was one of the millions of women suffering from it.”

Humans get iron from food and iron supplements, red meat being the most typical source of iron, as the iron in plants absorbs poorly. However, meat consumption is increasingly problematic due to its negative impact on the environment and individual’s health. As women are more likely to adopt the planetary health diet, the issue of iron deficiency grows within the female population.

On the other hand, the current iron supplements cause a variety of side effects, from digestive problems to nausea and even organ damage – which is due to the fact that more than 90% of the iron in the supplements goes through our digestive tract, as our bodies are unable to absorb the iron.

For more severe cases of anemia, iron infusion therapy is recommended, where iron is injected straight into muscles or into the blood vessels. The treatment is currently highly inaccessible due to its sky-high price – one treatment might cost anything between 2,000 to 4,000 euros.

“New ingredients like this enable the food industry to tackle a global health problem with new products. Worries about iron uptake are also a significant barrier to reducing the use of red meat in the Western diet. Putting a fundamental innovation like this to work takes effort, talent, and a bit of time. As an early investor, we work tightly with the team to build a solid foundation for success,” says Louise Heiberg, Investment Director at Nordic Foodtech VC.

Unlike the current supplements, Ironic Biotech’s patented compounds have no side effects of current iron supplements, making it the perfect ingredient for the food and supplement industry. The compounds are tasteless, and due to their stable form, they can be stored at room temperature for long periods of time. The absorption rates are comparable to the iron in meat, making Ironic Biotech the perfect solution for consumers not getting enough iron in their diet. This also solves the iron efficiency problem for companies looking for ways to make their products fit predominantly plant-based diets.

“Our team wants to empower women and put an end to the tiredness and fatigue caused by iron deficiency. I refuse to believe that being a woman should mean constantly feeling drained. I am determined to provide a solution that truly works,” Leiva concludes.

The company was founded in 2020 by Nélida Leiva Eriksson, who holds a PhD in protein design and molecular biology and has worked as a visiting fellow at Harvard and the University of Essex. In 2023 Nélida teamed up with Eskil Åhlin, who used to work for Sony as a global business developer, and Hans Holm, an innovation pioneer with more than 30 years of experience in the food ingredients and dietary supplement sectors.

About Ironic Biotech

Ironic Biotech is a Swedish biotech startup that aims to help 2 billion people across the globe suffering from iron deficiency and anemia. Our patented iron protein is easy to absorb with no side effects, making it the perfect ingredient for food and supplement companies that want to add effective iron into their products.

At Ironic Biotech, we believe in science and human values. We use biotechnology to develop innovative and effective solutions for iron deficiency and other health issues. We are transparent about our methods and results, and we uphold the highest standards of integrity and ethics. We are also committed to gender equality and social responsibility, both within our company and in the communities we serve.

Established in Lund, Sweden, in 2020, by Dr. Nélida Leiva Eriksson. Ironic Biotech is ready to empower women and put an end to the tiredness and fatigue caused by iron deficiency. Ironic Biotech has been endorsed by the Royal Swedish Academy of Engineering Sciences, and it has won the Vinnova Innovative Startups grant and Sten K Johnson foundation awards.

Read more at: www.ironicbiotech.com